HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Paranasal Sinus Cancer

Paranasal sinus cancer is a rare form of cancer that originates in the paranasal sinuses, which are air-filled spaces located within the bones of the face surrounding the nasal cavity. These sinuses play a crucial role in humidifying and filtering the air we breathe. While paranasal sinus cancer is uncommon, its impact can be significant. The exact cause of paranasal sinus cancer is not well understood, but certain risk factors may increase the likelihood of its development. These factors include exposure to certain workplace materials, such as wood dust or certain metals, as well as a history of chronic sinusitis or nasal polyps. Additionally, tobacco and alcohol use have been identified as potential risk factors. Symptoms of paranasal sinus cancer can be subtle in the early stages, making early detection challenging. Common signs include persistent nasal congestion, frequent nosebleeds, facial pain or numbness, and changes in vision or double vision. As the cancer progresses, individuals may also experience headaches, unintentional weight loss, and swelling or lumps on the face. Diagnosis typically involves a thorough examination by an ear, nose, and throat specialist, along with imaging studies such as CT scans or MRIs. A biopsy is often performed to confirm the presence of cancerous cells. Treatment options for paranasal sinus cancer depend on various factors, including the stage of the cancer, its location, and the overall health of the patient. Common approaches include surgery, radiation therapy, and sometimes chemotherapy. Prognosis varies, and the outlook for individuals with paranasal sinus cancer depends on factors such as the extent of the disease at the time of diagnosis and the effectiveness of treatment. Early detection and prompt intervention can significantly improve the chances of successful outcomes.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp